1.14.99.1 adrenal gland - 672503 1.14.99.1 adrenal gland fetal 686417 1.14.99.1 amnion - 670524 1.14.99.1 ATDC-5 cell - 745945 1.14.99.1 blood platelet - 727873 1.14.99.1 brain - 686417 1.14.99.1 brain fetal brain 698086 1.14.99.1 brain cortex - 672503, 673515 1.14.99.1 brain stem - 673515, 686417 1.14.99.1 brain stem PGHS-2 has lowest abundance in brain stem and pituitary gland 698086 1.14.99.1 brain stem PGSHS-1 has lowest abundance in brain stem and pituitary gland 698086 1.14.99.1 bronchial epithelium - 728294 1.14.99.1 cerebellum - 673515, 686417, 698086 1.14.99.1 cerebral cortex - 686417 1.14.99.1 cerebral cortex PGHS-2 has highest abundance in hippocampus and cerebral cortex 698086 1.14.99.1 cerebral cortex PGSHS-1 has highest abundance in hippocampus and cerebral cortex 698086 1.14.99.1 cervical mucosa - 727121 1.14.99.1 cervicovaginal cell seminal plasma induces and potentiates the expression of PTGS2 in cervicovaginal cells and tissues 727121 1.14.99.1 chondrocyte - 745945 1.14.99.1 chondrogenic MCT cell - 745945 1.14.99.1 chorion - 670524 1.14.99.1 colorectal cancer cell - 716434 1.14.99.1 corpus luteum PTGS1 enzyme activity is higher in late corpora lutea and lower in regressive ones 727567 1.14.99.1 corpus luteum PTGS2 increases from early to late corpora lutea and lowers in regressive ones 727567 1.14.99.1 corpus luteum significant increase in mRNA for PGHS-2 after treatment with prostaglandin F2alpha. PGHS-1 mRNA content remains unchanged 658374 1.14.99.1 decidua - 670524 1.14.99.1 embryo - 714943 1.14.99.1 endometrium - 746529 1.14.99.1 endometrium endometrial stromal cells 684980 1.14.99.1 endothelial cell cerebral 659785 1.14.99.1 epididymis caput and cauda 672503 1.14.99.1 epithelium stroma 684980 1.14.99.1 fetal membrane - 670524 1.14.99.1 fibroblast - 438393 1.14.99.1 granulosa cell - 659436 1.14.99.1 granulosa cell periovulatory granulosa cell 697636 1.14.99.1 HEK-293FT cell - 744616 1.14.99.1 hippocampus - 673515, 686417 1.14.99.1 hippocampus PGHS-2 has highest abundance in hippocampus and cerebral cortex 698086 1.14.99.1 hippocampus PGSHS-1 has highest abundance in hippocampus and cerebral cortex 698086 1.14.99.1 hypothalamus fetal 686417 1.14.99.1 kidney medulla 438389 1.14.99.1 large luteal cell PTGS2, during early, mid, and late stages 727567 1.14.99.1 liver - 672503, 698079 1.14.99.1 lung - 438391, 672503 1.14.99.1 MCF-7 cell - 744616 1.14.99.1 monocyte isozyme 2 438405 1.14.99.1 additional information distribution in different organs 438410 1.14.99.1 additional information distribution of isozymes 1,2 in gastrointestinal tissues 438403 1.14.99.1 additional information enzyme can be associated with endoplasmic reticulum, nuclear envelope and plasma membrane even within the same cell 438381, 438382 1.14.99.1 additional information quantitative real-time RT-PCR enzyme expression analysis, overview 728294 1.14.99.1 additional information quantitative RT-PCR enzyme expression and immunohistochemic analysis, overview 727121 1.14.99.1 additional information relationship of PGHS-2 and PGHS-1 mRNA and activity in brain tissues, overview 686417 1.14.99.1 myometrium - 438395 1.14.99.1 NCI-H292 cell - 728294 1.14.99.1 non-small cell lung cancer cell increased expression of PTGS2 728294 1.14.99.1 ovarian surface epithelium - 746529 1.14.99.1 ovary - 438410, 744794 1.14.99.1 ovary ovarian surface epithelium 673765 1.14.99.1 pituitary gland fetal 686417 1.14.99.1 pituitary gland PGHS-2 has lowest abundance in brain stem and pituitary gland 698086 1.14.99.1 pituitary gland PGSHS-1 has lowest abundance in brain stem and pituitary gland 698086 1.14.99.1 platelet - 673459 1.14.99.1 platelet isozyme 1 438405 1.14.99.1 prostate gland - 438404 1.14.99.1 prostate gland anterior prostate 672503 1.14.99.1 renal cortex - 672503 1.14.99.1 seminal vesicle - 438369, 438370, 438371, 438372, 438374, 438375, 438379, 438381, 438383, 438384, 438385, 438386, 438387, 438388, 659705, 671047, 673508, 673809, 675273, 713706 1.14.99.1 seminal vesicle PGHS-1 676390 1.14.99.1 SK-N-AS cell human neuroblastoma cell 672839 1.14.99.1 small luteal cell PTGS1 727567 1.14.99.1 spleen - 438373 1.14.99.1 stomach - 438373 1.14.99.1 stomach fundus 438392 1.14.99.1 striatum - 673515 1.14.99.1 stromal cell - 746529 1.14.99.1 substantia nigra - 673515 1.14.99.1 testis somatic and spermatogenic cells 672503 1.14.99.1 thyroid gland - 438390 1.14.99.1 uterine endometrium - 697628, 701168 1.14.99.1 uterus - 697628 1.14.99.1 uterus in the stroma of endometrial epithelium 684980 1.14.99.1 vas deferens - 672503 1.14.99.1 vesicular gland - 699595, 714124 1.14.99.1 VK-2/E6E7 cell vaginal cell line, expression of prostaglandin-endoperoxide synthase 2, i.e. cyclooxygenase 2, in human vaginal cells in response to toll-like receptor ligands and other proinflammatory stimuli, such vaginal mucosal irritant nonoxynol-9, in a synergistic manner 727121